A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms

Authors: Joel Rivera-Concepcion, Ying-Chun Lo, Dipesh Uprety, Alex A. Adjei, Vinicius Ernani, Konstantinos Leventakos

Source: Current Problems in Cancer: Case Reports, Vol 13, Iss , Pp 100284- (2024)

Subject Terms: NSCLC, EGFR mutation, Histologic transformation, Acquired resistance, Neuroendocrine cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666621924000073; https://doaj.org/toc/2666-6219

Access URL: https://doaj.org/article/89b01e3fc5fe4031b3866f1dd44b3b45

Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment

Authors: Ying-Chun Lo, MD, PhD, Joel Rivera-Concepcion, MD, George Vasmatzis, PhD, Marie-Christine Aubry, MD, Konstantinos Leventakos, MD, PhD

Source: JTO Clinical and Research Reports, Vol 4, Iss 9, Pp 100561- (2023)

Subject Terms: Small cell lung carcinoma, Subtype, Targeted therapy, Treatment effect, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364323001042; https://doaj.org/toc/2666-3643

Access URL: https://doaj.org/article/3d147a6b289f4e73b961f1a09509fc15